188 related articles for article (PubMed ID: 37248406)
1. Three genes expressed in relation to lipid metabolism considered as potential biomarkers for the diagnosis and treatment of diabetic peripheral neuropathy.
Yang Y; Wang Q
Sci Rep; 2023 May; 13(1):8679. PubMed ID: 37248406
[TBL] [Abstract][Full Text] [Related]
2. Gene expression profiling reveals candidate biomarkers and probable molecular mechanism in diabetic peripheral neuropathy.
Zhou H; Zhang W
Diabetes Metab Syndr Obes; 2019; 12():1213-1223. PubMed ID: 31413612
[TBL] [Abstract][Full Text] [Related]
3. Bioinformatics prediction and experimental verification of key biomarkers for diabetic kidney disease based on transcriptome sequencing in mice.
Zhao J; He K; Du H; Wei G; Wen Y; Wang J; Zhou X; Wang J
PeerJ; 2022; 10():e13932. PubMed ID: 36157062
[TBL] [Abstract][Full Text] [Related]
4. Identification of genes and signaling pathways associated with diabetic neuropathy using a weighted correlation network analysis: A consort study.
Li Y; Ma W; Xie C; Zhang M; Yin X; Wang F; Xu J; Shi B
Medicine (Baltimore); 2016 Nov; 95(47):e5443. PubMed ID: 27893688
[TBL] [Abstract][Full Text] [Related]
5. Identifying C1QB, ITGAM, and ITGB2 as potential diagnostic candidate genes for diabetic nephropathy using bioinformatics analysis.
Hu Y; Yu Y; Dong H; Jiang W
PeerJ; 2023; 11():e15437. PubMed ID: 37250717
[TBL] [Abstract][Full Text] [Related]
6. Identification of Key Genes Involved in Diabetic Peripheral Neuropathy Progression and Associated with Pancreatic Cancer.
Jian L; Yang G
Diabetes Metab Syndr Obes; 2020; 13():463-476. PubMed ID: 32110079
[TBL] [Abstract][Full Text] [Related]
7. Diagnostic biomarker for type 2 diabetic peripheral neuropathy via comprehensive bioinformatics analysis.
Chen X; Liu Q; Chen N; Ma J; Wu X; Zhang H; Yu L; Huang H
J Diabetes; 2024 Mar; 16(3):e13506. PubMed ID: 38018513
[TBL] [Abstract][Full Text] [Related]
8. Bioinformatics Analysis of the Mechanisms of Diabetic Nephropathy
Guo M; Dai Y; Jiang L; Gao J
Front Endocrinol (Lausanne); 2022; 13():934022. PubMed ID: 35909518
[TBL] [Abstract][Full Text] [Related]
9. Identification of potential biomarkers of vascular calcification using bioinformatics analysis and validation
Chen C; Wu Y; Lu HL; Liu K; Qin X
PeerJ; 2022; 10():e13138. PubMed ID: 35313524
[TBL] [Abstract][Full Text] [Related]
10. Identification of Immune Infiltration and the Potential Biomarkers in Diabetic Peripheral Neuropathy through Bioinformatics and Machine Learning Methods.
Li W; Guo J; Chen J; Yao H; Mao R; Li C; Zhang G; Chen Z; Xu X; Wang C
Biomolecules; 2022 Dec; 13(1):. PubMed ID: 36671424
[TBL] [Abstract][Full Text] [Related]
11. Bioinformatics analyses of significant genes, related pathways and candidate prognostic biomarkers in glioblastoma.
Zhou L; Tang H; Wang F; Chen L; Ou S; Wu T; Xu J; Guo K
Mol Med Rep; 2018 Nov; 18(5):4185-4196. PubMed ID: 30132538
[TBL] [Abstract][Full Text] [Related]
12. Screening of Lipid Metabolism-Related Genes as Diagnostic Indicators in Chronic Obstructive Pulmonary Disease.
Jiang C; Peng M; Dai Z; Chen Q
Int J Chron Obstruct Pulmon Dis; 2023; 18():2739-2754. PubMed ID: 38046983
[TBL] [Abstract][Full Text] [Related]
13. Integrated bioinformatics analysis for the screening of hub genes and therapeutic drugs in ovarian cancer.
Yang D; He Y; Wu B; Deng Y; Wang N; Li M; Liu Y
J Ovarian Res; 2020 Jan; 13(1):10. PubMed ID: 31987036
[TBL] [Abstract][Full Text] [Related]
14. The identification of key genes and pathways in hepatocellular carcinoma by bioinformatics analysis of high-throughput data.
Zhang C; Peng L; Zhang Y; Liu Z; Li W; Chen S; Li G
Med Oncol; 2017 Jun; 34(6):101. PubMed ID: 28432618
[TBL] [Abstract][Full Text] [Related]
15. Identification of Hub Genes Associated with Tumor-Infiltrating Immune Cells and ECM Dynamics as the Potential Therapeutic Targets in Gastric Cancer through an Integrated Bioinformatic Analysis and Machine Learning Methods.
Liu J; Cheng Z
Comb Chem High Throughput Screen; 2023; 26(4):653-667. PubMed ID: 35996248
[TBL] [Abstract][Full Text] [Related]
16. Identification of differentially expressed genes associated with coronary in-stent restenosis by integrated bioinformatics approaches.
Chen M; Dun Y; Zhang W; Liu S
Ann Palliat Med; 2022 Jun; 11(6):1940-1953. PubMed ID: 35144391
[TBL] [Abstract][Full Text] [Related]
17. RNA sequencing and bioinformatics analysis of differentially expressed genes in the peripheral serum of ankylosing spondylitis patients.
Bie Y; Zheng X; Chen X; Liu X; Wang L; Sun Y; Kou J
J Orthop Surg Res; 2023 May; 18(1):394. PubMed ID: 37254181
[TBL] [Abstract][Full Text] [Related]
18. Integrated Bioinformatics Analysis for the Screening of Hub Genes and Therapeutic Drugs in Hepatocellular Carcinoma.
Su Q; Li W; Zhang X; Wu R; Zheng K; Zhou T; Dong Y; He Y; Wang D; Ran J
Curr Pharm Biotechnol; 2023; 24(8):1035-1058. PubMed ID: 35762549
[TBL] [Abstract][Full Text] [Related]
19. Identification of Potential Genetic Biomarkers and Target Genes of Peri-Implantitis Using Bioinformatics Tools.
Zhang X; Wang Z; Hu L; Shen X; Liu C
Biomed Res Int; 2021; 2021():1759214. PubMed ID: 34931168
[TBL] [Abstract][Full Text] [Related]
20. Identification of candidate biomarkers and pathways associated with SCLC by bioinformatics analysis.
Wen P; Chidanguro T; Shi Z; Gu H; Wang N; Wang T; Li Y; Gao J
Mol Med Rep; 2018 Aug; 18(2):1538-1550. PubMed ID: 29845250
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
